Seth Fischer

Seth H.
Z.
Fischer currently serves as an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. since 2023 and as an Advisor at Healthquest Capital Management Co LLC.
Formerly, Mr. Fischer was Chief Executive Officer & Director at VIVUS, Inc. from 2013 to 2017; Group Chairman at Biosense Webster, Inc. from 2008 to 2012; Group Chairman at Janssen Pharmaceuticals, Inc. in 2013; Group Chairman at North American Pharmaceuticals Co. from 2004 to 2007; Chairman-Worldwide Franchise at Cordis Corp.
from 2008 to 2012; Group Chairman at Johnson & Johnson from 1983 to 2012; Group Chairman at Scios, Inc. in 2013; Chairman & President at Ortho-McNeil Pharmaceutical LLC from 2000 to 2004; Director at Streamex Corp.
from 2013 to 2019; Director at Trius Therapeutics, Inc. in 2013; Director at Spectrum Pharmaceuticals, Inc. from 2020 to 2023; Lead Independent Director at Agile Therapeutics, Inc. from 2020 to 2024; Independent Director at Immedica Pharma US, Inc. from 2016 to 2025; and Independent Director at Esperion Therapeutics, Inc. from 2021 to 2026.
Education includes an undergraduate degree from The Ohio University conferred in 1977.